Bloomberg Intelligence
Moderna: We Can Change Vaccine 'Code' To Fight New Variants
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Dr. Noubar Afeyan, Chairman and co-Founder of Moderna and Founder & CEO of Flagship Pioneering, on their next generation covid-19 vaccine and distribution outlook. Ed Al-Hussainy, Senior Interest Rates and Currencies Analyst for Columbia Threadneedle Investments, on the Fed, the dollar, and currencies. Max Abelson, Bloomberg finance reporter, on Trump’s ailing empire. Chris Bryant, Bloomberg Opinion industrials columnist, on his column: “Elon Musk Has a Serious Rival - the TechnoKaiser.” Hosted by Paul Sweeney and Matt Miller. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.